• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.使用尿激酶激活的炭疽毒素剖析尿激酶激活途径。
Methods Mol Biol. 2009;539:175-90. doi: 10.1007/978-1-60327-003-8_10.
2
Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin.细胞表面尿激酶型纤溶酶原激活物依赖性炭疽毒素对肿瘤细胞的靶向作用
J Biol Chem. 2001 May 25;276(21):17976-84. doi: 10.1074/jbc.M011085200. Epub 2001 Mar 12.
3
Potent antitumor activity of a urokinase-activated engineered anthrax toxin.尿激酶激活的工程化炭疽毒素具有强大的抗肿瘤活性。
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):657-62. doi: 10.1073/pnas.0236849100. Epub 2003 Jan 13.
4
Antitumor efficacy of a urokinase activation-dependent anthrax toxin.一种尿激酶激活依赖性炭疽毒素的抗肿瘤疗效。
Mol Cancer Ther. 2006 Jan;5(1):89-96. doi: 10.1158/1535-7163.MCT-05-0163.
5
Anthrax toxin: structures, functions and tumour targeting.炭疽毒素:结构、功能及肿瘤靶向性
Expert Opin Biol Ther. 2003 Aug;3(5):843-53. doi: 10.1517/14712598.3.5.843.
6
Production of recombinant lethal factor of in .在 中生产重组的 致死因子。
Prep Biochem Biotechnol. 2021;51(1):9-15. doi: 10.1080/10826068.2020.1762215. Epub 2020 May 12.
7
Imaging specific cell surface protease activity in living cells using reengineered bacterial cytotoxins.利用改造后的细菌细胞毒素对活细胞中的特定细胞表面蛋白酶活性进行成像。
Methods Mol Biol. 2009;539:115-29. doi: 10.1007/978-1-60327-003-8_7.
8
Comparative toxicity and efficacy of engineered anthrax lethal toxin variants with broad anti-tumor activities.具有广谱抗肿瘤活性的工程炭疽致死毒素变体的比较毒性和疗效。
Toxicol Appl Pharmacol. 2014 Sep 1;279(2):220-9. doi: 10.1016/j.taap.2014.06.010. Epub 2014 Jun 24.
9
A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types.一种尿激酶激活的重组炭疽毒素对多种人类肿瘤细胞类型具有选择性细胞毒性。
Mol Cancer Ther. 2006 Oct;5(10):2556-62. doi: 10.1158/1535-7163.MCT-06-0315.
10
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.在基因缺陷小鼠中产生的抗小鼠尿激酶型纤溶酶原激活物受体的鼠单克隆抗体:对体内外受体介导的尿激酶型纤溶酶原激活物活性的抑制作用
Thromb Haemost. 2007 Jun;97(6):1013-22.

引用本文的文献

1
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study.用工程化炭疽毒素靶向犬乳腺肿瘤上皮细胞:初步研究。
Vet Res Commun. 2024 Aug;48(4):2407-2428. doi: 10.1007/s11259-024-10400-5. Epub 2024 May 28.
2
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.一种改良炭疽毒素对犬和人骨肉瘤细胞的抑制作用。
Toxins (Basel). 2020 Sep 24;12(10):614. doi: 10.3390/toxins12100614.
3
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal Melanomas.重组炭疽毒素对犬口腔黏膜黑色素瘤的抑制作用。
Toxins (Basel). 2020 Mar 2;12(3):157. doi: 10.3390/toxins12030157.
4
Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.用致死因子-β-内酰胺酶融合蛋白测定原发性免疫细胞对炭疽毒素的摄取。
PLoS One. 2009 Nov 23;4(11):e7946. doi: 10.1371/journal.pone.0007946.

本文引用的文献

1
Characterization of the interaction between anthrax toxin and its cellular receptors.炭疽毒素与其细胞受体之间相互作用的表征
Cell Microbiol. 2007 Apr;9(4):977-87. doi: 10.1111/j.1462-5822.2006.00845.x.
2
Imaging specific cell-surface proteolytic activity in single living cells.对单个活细胞中的特定细胞表面蛋白水解活性进行成像。
Nat Methods. 2006 Apr;3(4):259-61. doi: 10.1038/nmeth862.
3
Genome engineering in Bacillus anthracis using Cre recombinase.利用Cre重组酶对炭疽芽孢杆菌进行基因组工程改造。
Infect Immun. 2006 Jan;74(1):682-93. doi: 10.1128/IAI.74.1.682-693.2006.
4
Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.炭疽芽孢杆菌水肿毒素可在小鼠中引起广泛的组织损伤并导致快速死亡。
Am J Pathol. 2005 Nov;167(5):1309-20. doi: 10.1016/S0002-9440(10)61218-7.
5
Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis.炭疽芽孢杆菌毒素分级分离时发现的第三种成分对大鼠的快速致死作用。
J Bacteriol. 1962 Jun;83(6):1274-80. doi: 10.1128/jb.83.6.1274-1280.1962.
6
Anthrax toxin: structures, functions and tumour targeting.炭疽毒素:结构、功能及肿瘤靶向性
Expert Opin Biol Ther. 2003 Aug;3(5):843-53. doi: 10.1517/14712598.3.5.843.
7
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.人毛细血管形态发生蛋白2作为炭疽毒素受体发挥作用。
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5170-4. doi: 10.1073/pnas.0431098100. Epub 2003 Apr 16.
8
Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.炭疽毒素通过脂筏介导的网格蛋白依赖性过程触发其受体的内吞作用。
J Cell Biol. 2003 Feb 3;160(3):321-8. doi: 10.1083/jcb.200211018. Epub 2003 Jan 27.
9
Potent antitumor activity of a urokinase-activated engineered anthrax toxin.尿激酶激活的工程化炭疽毒素具有强大的抗肿瘤活性。
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):657-62. doi: 10.1073/pnas.0236849100. Epub 2003 Jan 13.
10
Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.细胞表面肿瘤内皮标志物8的胞质尾非依赖性炭疽毒素结合、蛋白水解加工、寡聚体形成及内化作用。
J Biol Chem. 2003 Feb 14;278(7):5227-34. doi: 10.1074/jbc.M210321200. Epub 2002 Dec 4.

使用尿激酶激活的炭疽毒素剖析尿激酶激活途径。

Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.

作者信息

Liu Shihui, Bugge Thomas H, Frankel Arthur E, Leppla Stephen H

机构信息

Laboratory of Bacterial Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

出版信息

Methods Mol Biol. 2009;539:175-90. doi: 10.1007/978-1-60327-003-8_10.

DOI:10.1007/978-1-60327-003-8_10
PMID:19377974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3393601/
Abstract

Anthrax toxin is a three-part toxin secreted by Bacillus anthracis, consisting of protective antigen (PrAg), edema factor (EF), and lethal factor (LF). To intoxicate host mammalian cells, PrAg, the cell-binding moiety of the toxin, binds to cells and is then proteolytically activated by furin on the cell surface, resulting in the active heptameric form of PrAg. This heptamer serves as a protein-conducting channel that translocates EF and LF, the two enzymatic moieties of the toxin, into the cytosol of the cells where they exert cytotoxic effects. The anthrax toxin delivery system has been well characterized. The amino-terminal PrAg-binding domain of LF (residues 1-254, LFn) is sufficient to allow translocation of fused "passenger" polypeptides, such as the ADP-ribosylation domain of Pseudomonas exotoxin A, to the cytosol of the cells in a PrAg-dependent process. The protease specificity of the anthrax toxin delivery system can also be reengineered by replacing the furin cleavage target sequence of PrAg with other protease substrate sequences. PrAg-U2 is such a PrAg variant, one that is selectively activated by urokinase plasminogen activator (uPA). The uPA-dependent proteolytic activation of PrAg-U2 on the cell surface is readily detected by western blotting analysis of cell lysates in vitro, or cell or animal death in vivo. Here, we describe the use of PrAg-U2 as a molecular reporter tool to test the controversial question of what components are required for uPAR-mediated cell surface pro-uPA activation. The results demonstrate that both uPAR and plasminogen play critical roles in pro-uPA activation both in vitro and in vivo.

摘要

炭疽毒素是由炭疽芽孢杆菌分泌的一种三部分组成的毒素,由保护性抗原(PrAg)、水肿因子(EF)和致死因子(LF)组成。为了使宿主哺乳动物细胞中毒,毒素的细胞结合部分PrAg与细胞结合,然后在细胞表面被弗林蛋白酶进行蛋白水解激活,产生活性七聚体形式的PrAg。这种七聚体作为一个蛋白质传导通道,将毒素的两个酶部分EF和LF转运到细胞胞质溶胶中,在那里它们发挥细胞毒性作用。炭疽毒素递送系统已得到充分表征。LF的氨基末端PrAg结合结构域(第1 - 254位氨基酸,LFn)足以使融合的“乘客”多肽(如铜绿假单胞菌外毒素A的ADP核糖基化结构域)在依赖PrAg的过程中转位到细胞胞质溶胶中。通过将PrAg的弗林蛋白酶切割靶序列替换为其他蛋白酶底物序列,也可以对炭疽毒素递送系统的蛋白酶特异性进行重新设计。PrAg-U2就是这样一种PrAg变体,它被尿激酶型纤溶酶原激活剂(uPA)选择性激活。通过对体外细胞裂解物进行蛋白质印迹分析,或对体内细胞或动物死亡情况进行检测,很容易检测到PrAg-U2在细胞表面的uPA依赖性蛋白水解激活。在这里,我们描述了使用PrAg-U2作为分子报告工具来测试关于uPAR介导的细胞表面pro-uPA激活需要哪些成分这一有争议问题。结果表明,uPAR和纤溶酶原在体外和体内的pro-uPA激活中都起着关键作用。